ConductScience.org, home

Paper32905677

Pharmacologic Treatment of Attention Deficit-Hyperactivity Disorder.

Cortese S. N Engl J Med, 2020. Cited by 266 papers, by iCite.

Cite this record

ConductScience Library. Pharmacologic Treatment of Attention Deficit-Hyperactivity Disorder. Papers, record 32905677. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32905677

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pharmacologic Treatment of Attention Deficit-Hyperactivity Disorder.
PubMed
Journal
N Engl J Med
PubMed
Year
2020
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
266
iCite
Relative citation ratio, by iCite
19.4
iCite
Revised in PubMed
2020-10-08
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Cortese SSamuele

Source PubMed

Download CSV of authors

Topics17

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Attention Deficit Disorder with HyperactivityMajor topic
Adolescent
Adult
Amphetamines
Atomoxetine Hydrochloride
Child
Child, Preschool
Growth
Guanfacine
Heart Rate
Humans
Hypertension
Methylphenidate
Patient Dropouts
Polymers
Practice Guidelines as Topic
Treatment Outcome

Source PubMed

Download CSV of topics

Cited by177

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 266 citations.

PMIDTitleJournalYearIn PapersSource
42847833Investigating Potential Adverse Drug Reactions of Lisdexamfetamine Using Sequence Symmetry Analysis.Basic Clin Pharmacol Toxicol2026https://conductscience.org/library/papers/42847833PubMed
42819375Age-stratified safety signal mining of ADHD medications in pediatric populations using the FAERS database (2014-2024): a pharmacovigilance study using multi-method disproportionality analysis.Front Pediatr2026https://conductscience.org/library/papers/42819375PubMed
42749337Regulatory reform and adult methylphenidate dispensing in France: a nationwide interrupted time-series study.BMJ Ment Health2026https://conductscience.org/library/papers/42749337PubMed
42745761County-level variation and trajectories in ADHD medication dispensing among Norwegian children and adolescents, 2005-2022: a nationwide prescription register study.Front Psychiatry2026https://conductscience.org/library/papers/42745761PubMed
42724543The association of ADHD and ADHD medication with adherence to pharmacotherapy for type 2 diabetes: a population-based cohort study from seven countries.EClinicalMedicine2026https://conductscience.org/library/papers/42724543PubMed
42627426Clinical practices in ADHD management across Europe: findings from the ESCAP research academy survey.Eur Child Adolesc Psychiatry2026https://conductscience.org/library/papers/42627426PubMed
42595937
Candidate Clinico-Demographic Predictors or Moderators of Efficacy and Tolerability of Pharmacological Treatment in Attention-Deficit/Hyperactivity Disorder (ADHD): An Analysis of the MED-ADHD Repository of Randomised Controlled Trials.
CNS Drugs2026https://conductscience.org/library/papers/42595937PubMed
42580811Real-world ADHD pharmacological treatment patterns and their association with negative clinical outcomes in youth with comorbid autism: a Swedish population-based study.BMJ Ment Health2026https://conductscience.org/library/papers/42580811PubMed
42555602Medication use, social determinants of health, and latent trajectories of functional outcomes in children with attention-deficit/hyperactivity disorder.PLoS One2026https://conductscience.org/library/papers/42555602PubMed
42547686Pharmacokinetics at Different Application Sites and Dermal Safety Analysis of Dextroamphetamine Transdermal System (d-ATS) in Healthy Adults and Patients with ADHD.Adv Ther2026https://conductscience.org/library/papers/42547686PubMed
42539539Exercise combined with pediatric Tuina and auricular acupressure for children with attention-deficit/hyperactivity disorder: a randomized controlled trial.Front Med (Lausanne)2026https://conductscience.org/library/papers/42539539PubMed
42514426Probiotic Supplementation in Children and Adolescents with ADHD: A Systematic Review and Meta-Analysis of ADHD-Related and Emotional-Behavioral Outcomes.Nutrients2026https://conductscience.org/library/papers/42514426PubMed
42434320A Descriptive Review of Nordic Clinical Practice Guidelines for Pediatric ADHD: Evaluating the Evidence Base for Methylphenidate.Scand J Child Adolesc Psychiatr Psychol2026https://conductscience.org/library/papers/42434320PubMed
42363137
Trends in methylphenidate dispensing and regional inequalities among children and adolescents in France around the 2021 prescription reform: a repeated cross-sectional ecological analysis of national data (2014-2024).
BMC Public Health2026https://conductscience.org/library/papers/42363137PubMed
42352064Physalis angulata Leaf Extract Attenuates H2O2-Induced Neurotoxicity in Zebrafish Through Metabolomic Evidence of Antioxidant Pathway Restoration.Antioxidants (Basel)2026https://conductscience.org/library/papers/42352064PubMed
42331561ADHD medication discontinuation and non-adherence: a Norwegian population-based register study.BMJ Ment Health2026https://conductscience.org/library/papers/42331561PubMed
42288756Exploring adolescents' and parents' experiences of pharmacological and non-pharmacological treatment in ADHD: a qualitative study.BMC Psychiatry2026https://conductscience.org/library/papers/42288756PubMed
42168718The Evolving Pharmacological Landscape for Paediatric and Adult ADHD.CNS Drugs2026https://conductscience.org/library/papers/42168718PubMed
42152117Cross-training digital therapeutics for pediatric ADHD: study protocol for a randomized controlled trial.Trials2026https://conductscience.org/library/papers/42152117PubMed
42139800Reinventing amlodipine.J Pharmacol Exp Ther2026https://conductscience.org/library/papers/42139800PubMed

See all 177 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32905677

GET https://conductscience.org/api/papers/v1/32905677/cited_by?page=2